Annals of Indian Academy of Neurology
REVIEW: MANAGEMENT UPDATES
Year
: 2009  |  Volume : 12  |  Issue : 4  |  Page : 283--290

Promising treatments of tomorrow for multiple sclerosis


Daniel M Harrison, Peter A Calabresi 
 Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Correspondence Address:
Daniel M Harrison
Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University, School of Medicine, 600 North Wolfe Street Pathology 627, Baltimore, Maryland 21287
USA

The therapeutic options for multiple sclerosis are rapidly expanding. What was once seen as a disease with little hope for treatment is now a target of rapid drug development. Current therapies have demonstrated efficacy in limiting the impact of the disease, but none is fully effective in all patients. However, promising new treatments are on the horizon. In this review we will discuss potential novel immunomodulating drugs that are in advanced stages of investigation; these drugs include monoclonal antibodies, chimeric molecules, and oral therapies. The use of hematopoietic stem cells will also be discussed and, in addition, we will look farther ahead at possible novel targets for the development of new immunomodulatory or neuroprotective pharmaceuticals.


How to cite this article:
Harrison DM, Calabresi PA. Promising treatments of tomorrow for multiple sclerosis.Ann Indian Acad Neurol 2009;12:283-290


How to cite this URL:
Harrison DM, Calabresi PA. Promising treatments of tomorrow for multiple sclerosis. Ann Indian Acad Neurol [serial online] 2009 [cited 2022 Oct 7 ];12:283-290
Available from: https://www.annalsofian.org/article.asp?issn=0972-2327;year=2009;volume=12;issue=4;spage=283;epage=290;aulast=Harrison;type=0